CLEC4F and Hepatic fibrosis: investigated the mechanism of action of sorafenib in liver fibrosis.[56] They revealed a decrease in total Kcr in a liver fibrosis mouse model, caused by upregulation of the crotonyl erasers HDAC1, HDAC3, and CDYL.